Cardinal Health, Inc. $CAH Shares Sold by Thomasville National Bank

Thomasville National Bank cut its holdings in shares of Cardinal Health, Inc. (NYSE:CAHFree Report) by 26.6% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 6,585 shares of the company’s stock after selling 2,391 shares during the period. Thomasville National Bank’s holdings in Cardinal Health were worth $1,353,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of the business. SJS Investment Consulting Inc. lifted its position in shares of Cardinal Health by 1,363.6% during the 3rd quarter. SJS Investment Consulting Inc. now owns 161 shares of the company’s stock valued at $25,000 after buying an additional 150 shares in the last quarter. Aventura Private Wealth LLC acquired a new position in shares of Cardinal Health during the 4th quarter worth about $25,000. Jones Financial Companies Lllp raised its position in shares of Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after purchasing an additional 14,034 shares during the last quarter. JPL Wealth Management LLC purchased a new position in Cardinal Health in the 3rd quarter valued at about $31,000. Finally, Turning Point Benefit Group Inc. acquired a new stake in Cardinal Health in the 3rd quarter worth about $31,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Stock Up 0.7%

Shares of CAH opened at $213.22 on Friday. Cardinal Health, Inc. has a 52-week low of $129.52 and a 52-week high of $233.60. The stock has a fifty day simple moving average of $217.50 and a two-hundred day simple moving average of $202.17. The company has a market capitalization of $50.17 billion, a PE ratio of 30.68, a price-to-earnings-growth ratio of 1.36 and a beta of 0.64.

Cardinal Health (NYSE:CAHGet Free Report) last announced its quarterly earnings data on Thursday, February 5th. The company reported $2.63 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.31 by $0.32. Cardinal Health had a net margin of 0.68% and a negative return on equity of 92.50%. The firm had revenue of $65.63 billion during the quarter, compared to analyst estimates of $64.88 billion. During the same quarter in the prior year, the firm posted $1.93 earnings per share. Cardinal Health’s quarterly revenue was up 18.8% on a year-over-year basis. As a group, equities analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, April 15th. Stockholders of record on Wednesday, April 1st were issued a dividend of $0.5107 per share. The ex-dividend date was Wednesday, April 1st. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.0%. Cardinal Health’s dividend payout ratio (DPR) is currently 29.35%.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the company. Morgan Stanley set a $255.00 target price on Cardinal Health in a report on Friday, February 6th. Wall Street Zen cut shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Sunday, April 12th. Argus upped their target price on shares of Cardinal Health from $232.00 to $248.00 and gave the stock a “buy” rating in a report on Wednesday, February 11th. Zacks Research raised shares of Cardinal Health from a “hold” rating to a “strong-buy” rating in a research note on Thursday, February 12th. Finally, Robert W. Baird set a $252.00 price target on shares of Cardinal Health in a research report on Friday, February 6th. One research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, Cardinal Health currently has an average rating of “Moderate Buy” and an average target price of $244.33.

Read Our Latest Research Report on CAH

Cardinal Health Company Profile

(Free Report)

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

Featured Articles

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAHFree Report).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.